This study is the first to investigate COVID-19 vaccine hesitancy, vaccine safety and efficacy, and the effect of mTOR inhibitors on COVID-19 symptoms in LAM patients during the Omicron pandemic. The gene discussed is MTOR; the disease is COVID-19.